M itogen-activated protein kinases (MAPKs; ERK, p38, JNK) are serine/threonine kinases that mediate the cellular response to a variety of extracellular stimuli ranging from growth factors to inflammatory cytokines. The activity of MAPKs is finely tuned in a cell type-specific and temporal manner by the concerted effort of multiple regulatory proteins, including activating kinases (such as MEK1, MKK3 and MKK6), deactivating phosphatases (such as KIM-PTPs and MKPs) and scaffolding proteins (such as KSRs) 1 . Critically, disruptions in the tight regulation of the MAPK signaling pathways are directly correlated with numerous diseases, including Alzheimer's disease, rheumatoid arthritis and cancer 2 . The MAPK pathways consist of three components: a MAP kinase kinase kinase (MAP3K), a MAP kinase kinase (MAP2K) and a MAPK 3 . Stimulation of the pathway ultimately results in MAPK activation by the dual phosphorylation of a threonine and a tyrosine residue (Thr-Xaa-Tyr) located in the MAPK activation loop. Though the kinase cascades that direct MAPK activation seem stereotypical, the guidance and fine-tuning that direct cell-and situation-specific responses are governed by MAPK-specific phosphatases. In particular, MAPKs are dephosphorylated by the kinase interaction motif protein tyrosine phosphatases (KIM-PTPs), 11 'typical' MAP kinase phosphatases (MKPs) and several 'atypical' dual-specific phosphatases as well as serine/threonine phosphatases 4 . The reason for this abundance of phosphatases is most likely related to the many roles that MAPKs play in the cell, which is profoundly affected by the duration of MAPK activation and the subcellular localization of active MAPKs. A comprehensive understanding of how the activity of MAPKs is finely controlled by MAPK regulatory proteins can only be obtained by understanding how these proteins interact at a molecular level.
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MAPKs have a two-lobed architecture with a five-stranded β-sheet in the N-terminal lobe and six α helices in the C-terminal lobe 5 . The activation loop, which contains the Thr-Xaa-Tyr motif, is at the top of the C-terminal domain immediately adjacent to the N-terminal domain. In 1994, it was discovered that MAPKs contain a docking site in the C-terminal lobe 6 . This docking site is located on the face of the C-terminal lobe opposite to the activation loop and binds a conserved 13-to 16-amino-acid sequence known as the kinase interaction motif (KIM) or the D motif. This motif has since been identified in nearly every MAPK regulatory and substrate protein. The KIM is characterized by a group of basic residues (two to three lysines or arginines) and two hydrophobic residues (Φ A -Xaa-Φ B ) that mediate the interaction with the KIM binding site of MAPKs. Structures of MAPKs bound to KIM peptides from activating kinases, deactivating phosphatases and substrates have revealed new insights into the molecular determinants that direct these interactions [7] [8] [9] [10] [11] [12] [13] . However, though the KIM is required for binding 14, 15 , it has recently become clear that residues outside the KIM are necessary to confer specificity [16] [17] [18] . The KIM-PTPs are a small family of phosphatases that include hematopoietic tyrosine phosphatase (HePTP; immune systemspecific) 19 , striatum-enriched phosphatase (STEP; brain-specific) 20 and STEP-like PTP (PTPRR or PTP-SL; brain-specific) 21 . Each phosphatase possesses a C-terminal catalytic domain (the PTP domain) and an N-terminal unstructured extension that contains the 15-amino-acid KIM. KIM-PTPs regulate the activity of p38 and ERK by both protein localization (by retaining the MAPKs in the cytosol) and dephosphorylation of their active sites 22 . Despite a wealth of crystallographic data for p38 (refs. 5,7,8,23,24) , little is known about the atomic-level detail of its interaction with regulatory proteins outside the KIM binding pocket and the role that these residues have in distinguishing between MAPK regulatory proteins to ensure pathway specificity. Though current structures provide clues to the conformational variability in p38 in the free and KIM peptide-bound forms, additional structures are necessary to obtain comprehensive structural models that describe the molecular interactions between MAPKs and the fulllength regulatory proteins that define MAPK pathway specificity and fidelity. Here, we combine biomolecular NMR spectroscopy, smallangle X-ray scattering (SAXS) and isothermal titration calorimetry (ITC) to determine how p38α, the p38 isoform that is highly and ubiquitously expressed in most cell types, is recognized by its KIM-PTP regulator HePTP under functional conditions. We show that, although the KIM peptide is essential for binding, p38α residues outside the KIM binding pocket play a central role in HePTP recognition. We also show that the interaction between p38α and HePTP is largely confined to the unstructured HePTP N terminus and the KIM-PTP catalyticdomain extension. Finally, using SAXS and a new ensemblecalculation routine that incorporates chemical-shift information derived from NMR spectroscopy, we show that the complex adopts an extended conformation in solution and provide an atomic model of the p38α-HePTP complex. Collectively, these results provide new insights into the molecular interactions that regulate the strength and duration of MAPK signaling and, in turn, provide unique avenues for therapeutic interventions of MAPK-related diseases.
ReSulTS

Resting-state p38a analysis
NMR spectroscopy is a powerful technique for defining the interactions of proteins at atomic resolution. However, a precise definition of these interactions requires a highly complete sequence-specific backbone assignment of the protein (or proteins) under investigation. Because of their large size (~40 kDa) and complex dynamic characteristics, serine/threonine kinases are notoriously difficult targets for NMR spectroscopy, and only a few of them, such as the serine/threonine kinase PKA 25, 26 and the tyrosine kinase Abl 27 , have been investigated in detail using this technique. This is especially true for the MAPKs, for which only two sequence-specific backbone assignments have been reported 28, 29 . However, unlike the assignments for PKA (80% complete) 30 or Abl (96% complete) 31 , the assignment of p38α is only partially complete (64% complete) 29 . Moreover, many functionally important residues are unassigned.
To further our understanding of these previously unassigned regions of p38α, we improved the sequence-specific backbone assignment of p38α to 82% (Fig. 1a-d 1  15  29  43  57  71  85  99  113  127  141  155  169  183  197  Residue number   211  225  239  253  267  281  295  309  323  337   1  15  29  43  57  71  85  99  113  127  141  155  169  183  197  Residue number   211  225  239  253  267  281  295  309  323  337 for nonproline residues, 297 peaks were observed in the twodimensional 1 H, 15 N transverse relaxation-optimized spectroscopy (TROSY) spectrum of p38α. The 37 peaks not observed could be missing because of fast solvent (H 2 O)-amide exchange on the NMR timescale; lack of D 2 O back exchange after protein growth in D 2 O-based expression medium, especially for amino acids in the hydrophobic core; or intermediate conformational exchange, which broadens the peaks beyond detection. To minimize solventamide exchange, all experiments were performed at pH 6.8 using water suppression by gradient-tailored excitation (WATERGATE)-based NMR experiments. In addition, analysis of unassigned residues suggested that only a small fraction of residues are sufficiently buried in the hydrophobic core to be missing as a result of slow D 2 O back exchange. Thus, the majority of missing peaks are probably in a microsecond-millisecond conformational exchange regime that broadens the peaks beyond detection.
Most newly assigned residues are located in functionally critical regions of p38α (Fig. 1b) . The current assignment now includes 88% of the N-terminal lobe, including all of the GxGxxG ATP binding motif; 83% of the activation loop, which contains the Thr-Gly-Tyr phosphorylation site; 100% of the Thr-Gly-Tyr motif; 74% of the MAPK insert (residues 243-273), which includes helices α1L14 and α2L14 and forms a C-terminal domain binding pocket that is currently being exploited for the development of new p38-specific inhibitors 32 ; 100% of the αEF-αF loop, which forms a platform on which the activation loop folds; 100% of helix αH; and 93% of the KIM-peptide binding pocket. Taken together, this is the most complete sequence-specific backbone assignment of any MAPK reported to date.
The assignment of residues surrounding the ATP binding pocket were confirmed by titration of both 2′,3′-(2,2,5,5-tetramethyl-3-pyrroline-1-oxyl-3-carboxylic acid ester) adenosine triphosphate (SL-ATP) 33, 34 , a spin-labeled ATP analog, and the prototypical p38α inhibitor SB203580 (ref. 35 . 1c ). In addition, titration with SB203580 did not change the number of observed peaks (296 peaks), demonstrating that the microsecond-millisecond intermediate timescale dynamics of p38α are unchanged when it is bound to SB203580.
Notably, the largest contiguous patch of unassigned p38α residues connects the N-and the C-terminal lobes of p38α ( Supplementary Fig. 2a,b) . This connection is mediated by the DFG loop and stretches into the MAPK insert in the C-terminal lobe. Titration with BIRB796 ( Fig. 1d) , a prototypical DFG-out inhibitor that binds and stabilizes the DFG loop in the inactive 'out' conformation 36 , resulted not only in chemical shift perturbations of residues near the BIRB796 binding site but also in altered microsecond-millisecond intermediate timescale p38α dynamics, as a total of 15 additional peaks were observed in the spectrum. Thus, BIRB796 changes the conformational equilibrium of all DFG loop residues, including Phe169 (ref. 36) , as well as additional residues in this region (Supplementary Fig. 2c ). This is notable as this finding correlates well with a recently introduced model for the catalytic reactions of kinases that is based on hydrophobic spines that coordinate internal kinase dynamics 37 . The hydrophobic spine, the R-spine (Phe169, unassigned; Leu75, unassigned; Leu86, assigned; His148, assigned), is centered on the DFG loop. Our data show that stabilization of Phe169 (for example, by an inhibitor such as BIRB796) and, in turn, other spine residues such as Leu86 influence kinase dynamics.
The p38a docking site extends past the KiM binding pocket
We used NMR spectroscopy to define the complete p38α-HePTP resting-state complex interface at atomic resolution ( Fig. 2a-e) . . 2a) , the 78-kDa p38α-HePTP complex was purified by size-exclusion chromato graphy and a two-dimensional 1 H, 15 N-TROSY spectrum of the complex was recorded. The complex interacts tightly (K d = 2.5 ± 0.6 μM; Table 1 and Supplementary Fig. 3 ) and is stable for days at 23 °C. The spectrum is of excellent quality for a complex of this size (78 kDa), allowing the chemical shift perturbations in p38α caused by HePTP binding to be readily detected (Fig. 2b) .
Direct comparison of the two-dimensional (Fig. 3a,b) . As expected, a subset of the chemical shift perturbations were localized to the KIM binding pocket, including helix αD, the αD-αE loop, the β7-β8 reverse turn, the ED site and the CD site (the latter two sites are often collectively referred to as the acidic binding pocket). However, perturbation of residues that are distal to the KIM binding pocket were also detected, including multiple residues from the αC-β4 loop, the αE-β7 loop, helix αF and the αF-αG loop. To our knowledge, this demonstrates for the first time that residues outside the p38α KIM binding pocket contribute to HePTP interaction and thus are important for binding.
KiM interactions with MAPKs are determined by the KiM
The structure of the HePTP KIM peptide (HePTP residues [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] in complex with ERK2 (ref. 13) , as well as three structures of KIM peptides (one with MEF2a and two with MKK3b) bound to p38α (ref. 7, 8) , have been reported. In the p38α-KIM peptide complexes, no interaction of the peptides with the CD domain (Asp313 and Asp316) was observed. In contrast, the HePTP KIM peptide makes multiple contacts with the CD domain of ERK2. Our chemical shift perturbation data with the p38α-HePTP complex unequivocally confirm the interaction of HePTP with the p38α CD and ED domains in solution, which involves CD domain residues Gln310-Asp313, Asp315-Glu317 (Pro314 is undetectable in the two-dimensional 1 H, 15 N-TROSY spectrum) and ED residues Glu160 and Asp161. Thus, HePTP clearly interacts with both the ED and the CD sites in the p38α-HePTP complex and, based on the observed chemical shift changes, most likely adopts a conformation similar to that observed in the ERK2-HePTP KIM peptide complex. This demonstrates a critical point for MAPK selectivity: the sequence of the KIM, and not the identity of the MAPK, defines how KIM peptides from different MAPK effector proteins bind and interact with MAPKs.
To identify the residues of HePTP interacting with p38α, we isolated the individual domains of HePTP that most likely contribute to p38α binding, namely the KIM peptide (HePTP KIM31 ; Fig. 2a ) and the HePTP catalytic domain (HePTP CAT ; Fig. 2a) . We then used NMR chemical shift perturbation mapping experiments to determine which of these domains participate in binding. First, we probed the interaction of the HePTP KIM31 peptide with p38α at four different protein-peptide ratios (Supplementary Fig. 4 ). Upon addition of the HePTP KIM31 peptide to [ 2 H, 15 N]p38α, 35 large chemical shift changes corresponding to residues in the p38α C lobe and Leu108 in the hinge region were observed. Consistent with the p38α-HePTP complex chemical shift perturbation experiment, no substantial chemical shift differences were observed for peaks corresponding to residues in the p38α N-lobe (Figs. 2c and 3a,b) . Remarkably, the total number of perturbed peaks was lower in the titration of p38α with HePTP KIM31 than in the p38α-HePTP complex. Whereas complex formation between p38α and HePTP resulted in large chemical shift changes in multiple residues from helix αD, the αD-αE loop, the β7-β8 reverse turn, the ED site and the CD site, titration with HePTP KIM31 resulted in fewer shifts in these regions (Fig. 3a,b) . Moreover, titration with HePTP resulted in multiple shifts outside the KIM that were not observed with HePTP KIM31 alone. This shows that, though HePTP KIM31 binds and interacts with p38α, it does not recapitulate the shifts observed with HePTP, demonstrating that surfaces outside the KIM binding pocket are essential for the formation of the p38α-HePTP complex.
We also investigated the role of the HePTP residue Val31. Sequence alignments with other MAPK KIMs predicted that the HePTP Φ A -X-Φ B residues correspond to Leu27-Xaa-Leu29. However, the crystal structure of the ERK2-HePTP KIM peptide complex 13 revealed a register shift in the Φ A -Xaa-Φ B sequence in which Leu27 binds in Thus, Val31 putatively binds in the Φ B pocket. However, the absence of electron density observed for Val31 indicates flexibility and thus potential dispensability for binding. This is consistent with the observation that ERK2-bound KIM peptide conformations are heterogeneous, with only weak overlap between corresponding Φ A and Φ B residues. In contrast, the KIM peptides bound to p38α adopt highly similar conformations, and the corresponding Φ A and Φ B residues overlap nearly perfectly (Fig. 4a,b and Supplementary Fig. 5 ).
Because the Φ B interactions between KIM peptides and p38α are so highly conserved, we hypothesized that Val31 is not dispensable but instead has an important role in binding to p38α, which we examined again using NMR chemical shift mapping with the peptide HePTP KIM30 , which lacks Val31, at four different proteinpeptide ratios (Supplementary Fig. 4 ). The addition of Val31 resulted in a considerable increase in the number of residues that experienced chemical shift perturbations: from 23 (HePTP KIM30 ) to 35 (HePTP KIM31 ) (Fig. 3a,b) . The localization of the majority of additional shifts to the Φ B binding pocket indicates that this is the binding site for Val31 (Fig. 4b) . Remarkably, the addition of Val31 also resulted in a chemical shift perturbation of Leu108 in the hinge region, which connects the N and C lobes of p38α. This suggests that the domain closure mediated by the hinge in MAPKs upon KIM-peptide binding most likely requires occupation of the Φ B binding pocket. Unexpectedly, increases in the number of chemical shift perturbations for residues that contribute to the Φ A-2 and Φ A binding pockets, as well as the acidic binding pocket, were also observed for HePTP KIM31 . Taken together, these data suggest that HePTP KIM31 interacts more tightly with p38α than HePTP KIM30 . This was confirmed using ITC, which showed that the HePTP KIM31 binds p38α with a K d of 5.2 ± 1.3 μM ( Table 1 and Supplementary Fig. 3 ), whereas the K d for the HePTP KIM30 -p38α interaction was sufficiently weak that it could not be accurately determined. These results demon strate that HePTP KIM31 occupies all three hydrophobic binding pockets (Φ A-2 , Φ A and Φ B ) in p38α and provide additional evidence that the mechanism of MAPK binding is determined by the KIM sequence and not the MAPK.
The p38a activation loop is unaffected by HePTP binding
Crystallographic studies of MAPK-KIM peptide complexes have also shown that docking interactions alter the structure of the activation loop, resulting in a more 'active-like' conformation of the MAPK [7] [8] [9] [10] [11] [12] [13] 18 . To determine whether the same changes occur in solution, we examined the chemical shifts of the p38α activation loop residues (172-183) in p38α alone and bound to either the HePTP KIM31 peptide or the HePTP protein. Remarkably, no chemical shift perturbations were observed for any of the peaks corresponding to activation-loop residues (10 of the 12 residues are assigned, including the Thr-Gly-Tyr motif). This demonstrates that, in solution, binding of HePTP KIM31 or HePTP to p38α does not change the local environment of activation-loop residues.
p38a does not interact with HePTP CAT
It is well known that the HePTP KIM is necessary for the formation of a stable p38α-HePTP complex 15 . However, it is unknown whether weak NMR-detectable interactions (mM) occur between p38α and HePTP CAT . Thus, we probed the interaction of p38α with HePTP CAT , which lacks residues 1-43 but includes HePTP α0, a secondary structural element that is unique to the KIM-PTP family among the classical PTPs 38 . Surprisingly, we detected absolutely no interactions between p38α and HePTP CAT (Figs. 2d and 3b) . This was unexpected because activated p38α is dephosphorylated by HePTP 15 , and thus, at some point during catalysis, the phosphorylated tyrosine of the p38α activation loop must bind the HePTP active site. Thus, all chemical shift perturbations observed for the p38α-HePTP complex are mediated by residues N-terminal to HePTP CAT , namely, the HePTP KIM31 , and the residues immediately C-terminal to the HePTP KIM31 known as the kinase specificity sequence (KIS), namely, the HePTP KIS (ref. 16 ).
To confirm this hypothesis, we performed reverse NMR titration experiments with [ N-TROSY spectrum of HePTP overlaps nearly perfectly with that of HePTP CAT , demonstrating that there is no interaction between the residues N-terminal to the catalytic domain (residues 15-43) and HePTP CAT (Supplementary Fig. 6a ). This allowed us to transfer the previously published assignment of HePTP CAT (ref. 39) to that of HePTP. Additionally, the new peaks in the spectrum, owing to the additional 29 residues at the N terminus, were clustered at ~8.0 p.p.m., a chemical shift range typical for unstructured residues. We also detected chemical shift perturbations for residues 44-56 corresponding to helix α0, which indicate that the flexibility of residues 15-43 alters the chemical environment of residues 44-56.
To test the effect of p38α binding, the complex between [ 2 H, 15 N]HePTP and unlabeled p38α was formed, and a twodimensional 1 H, 15 N-TROSY spectrum of the 78-kDa complex was collected (Supplementary Fig. 6b ). All crosspeaks that clustered at ~8.0 p.p.m. in the free HePTP spectrum were perturbed in the spectrum of the p38α-HePTP complex, demonstrating that the flexible residues in HePTP, 15-56, bind strongly to p38α and adopt an ordered conformation. Thus, HePTP residues that mediate strong and specific p38α binding include not only the HePTP KIM31 peptide but also the HePTP KIS , which includes helix α0 (residues 31-56) and thus HePTP residues 15-56 (Supplementary Fig. 6c) . N]p38α (it also copurifies with p38α using size-exclusion chromatography). As predicted by our earlier studies, the chemical shift perturbation mapping of the HePTP KIMKIS peptide bound to p38α almost completely recapitulated that observed in the p38α-HePTP complex, demonstrating that all of the interactions between p38α and HePTP are mediated by the HePTP KIMKIS peptide (Figs. 2e and 3a,b) . We also performed a titration with 15 N-labeled HePTP KIMKIS peptide and unlabeled p38α as an additional experiment to show that all residues of the HePTP KIMKIS peptide bind to p38α (Supplementary Fig. 7) . Notably, the HePTP KIMKIS peptide interaction with p38α showed a few additional chemical shift perturbations. Correspondingly, it had an approximately three-fold increase in binding affinity over HePTP, as measured by ITC (Table 1 and Supplementary Fig. 3) . The additional interaction is most likely due to nonpolar contacts between HePTP KIS hydrophobic residues (Ile40, Val43, Pro46 and Val49) and p38α residues (Leu217, Thr218, His228, Asn269, Asn272, Phe274, Ile275 and Ala277). These p38α residues showed larger chemical shift perturbations when bound to the HePTP KIMKIS peptide than when in complex with HePTP. Thus, both NMR and ITC data show that the presence of HePTP CAT slightly weakens the interactions observed for p38α residues that preferentially interact with the HePTP KIMKIS peptide.
The p38a-HePTP complex solution structure SAXS provides information on the global size and shape of a protein in solution. The experimental scattering curve represents the average scattering of all conformations weighted by the number of molecules in each conformational state. We therefore used SAXS to determine the size and shape of the individual p38α and HePTP proteins and the p38α-HePTP complex in solution. SAXS profiles (I(q) versus q, with intensity I and scattering vector q) and pair-distribution functions are shown in Figure 5a ,b (p38α-HePTP complex) and Supplementary Figure 8 (p38α and HePTP alone) . The I 0 -to-concentration ratio was consistent for measurements of at least two concentrations, demonstrating no detectable aggregation and thus confirming the high quality of the samples. The experimental radius of gyration (R g ) value of 33.2 ± 0.5 Å for the p38α-HePTP complex was determined from Guinier analysis (n = 4; Supplementary Table 1) . As expected, this was considerably larger than that for either protein alone (R g = 23.7 ± 0.4 Å for 40 .
Collectively, these results demonstrate that in the resting state the p38α-HePTP complex is highly extended, with p38α and HePTP associating in a head-to-head, head-to-tail or tail-to-tail manner.
To further our understanding of the p38α-HePTP complex, we developed a new computational procedure, ensemble refinement of SAXS (EROS)-NMR, which allowed us to determine the relative orientation of p38α and HePTP that provides the best fit to the experimental SAXS data. EROS-NMR includes the key features of EROS 41 : a coarse-grained model for protein binding is used to simulate the molecular assembly, which generates an initial ensemble of starting protein conformations. This ensemble is subsequently refined to improve the fit to the SAXS data. In addition, EROS-NMR accounts for NMR chemical shift data by incorporating a bias in the initial p38α-HePTP simulation. Namely, a nonspecific attractive potential was applied between the HePTP KIS linker (HePTP residues 32-56) and the p38α residues (Asn114, Asn115, Lys118, Lys121, Ser154, Gly219, Arg220) that fulfill three conditions: they show large chemical shift changes, they are surface exposed and they are not in the vicinity of the p38 KIM binding pocket. The bias potential was weak so that the HePTP KIS linker could bind and unbind repeatedly from p38α during the course of the simulation. The conformational space occupied by these rigid bodies was thoroughly sampled by simulation to identify conformations that best fit the SAXS data.
The best fit to the experimental data (χ 2 = 1.3) was obtained for an ensemble of four conformations, which includes the singlebest-fit model (SBFM) with the highest relative weight (47%), as well as three additional models (relative weights 23%, 16%, 14%; Fig. 5c,d and Supplementary Fig. 9 ). This fit is considerably better than that observed for the SBFM alone (χ 2 = 1.5), for an ensemble that includes only two models (χ 2 = 1.4), or for ensembles with five or more models, as the inclusion of more models only marginally improves χ 2 . All models in the four-model ensemble are globally similar, with p38α and HePTP associating in an end-toend manner such that the HePTP CAT is localized to the bottom of the p38α C-terminal domain. They only differ in the position of the HePTP CAT domain. In fact, overlaying the models using p38α suggests that in solution the HePTP CAT fluctuates in a fan-like motion below p38α about the central SBFM conformation, with the weights of the additional models steadily decreasing as the distance from the SBFM increases (Supplementary Fig. 9 ). These changes in the position of HePTP CAT are accommodated by changes in the flexible HePTP KIS peptide, which adopts one of two classes of conformations: it either extends back toward the ATP binding pocket before bending down toward the bottom of the p38α C-terminal domain (the dominant SBFM conformation belongs to this class), or it bends down immediately after the last HePTP KIM residue. Remarkably, in none of the four structures was the active site of HePTP (Cys270) localized near the p38α activation loop, an interaction that must occur when HePTP dephosphorylates activated p38α. To quantify this important point, we also performed a full maximum-entropy refinement of 1,000 simulation structures 41 . The region of conformational space spanned by the resulting ensemble is consistent with that spanned by the smaller four-model ensemble, with, at most, 1% of structures in which the Cα atoms Tyr182 (p38α) and Cys270 (HePTP) are within 18 Å of each other (Supplementary Fig. 10) . Notably, the corresponding structures extend the fan-like motion previously seen for the four-conformer ensemble toward the p38α activation loop (Supplementary Fig. 9 ). Thus, under resting-state conditions, HePTP and p38α adopt an elongated end-to-end complex that rarely (<~1%) samples the orientation required for dephosphorylation.
DiSCuSSioN
It is commonly accepted that KIM peptides are only partially responsible for recognition of effector proteins by MAPKs, as multiple studies have shown that additional interactions between MAPK effectors and substrates are required to maintain the exquisite specificity observed in MAPK signaling pathways [16] [17] [18] . Here, we have combined the molecular detail provided by NMR spectroscopy with the overall molecular organization afforded by SAXS to determine which residues outside the HePTP KIM31 direct and stabilize the resting-state conformation of the p38α-HePTP complex. One of the central findings of this study is that the HePTP KIM31 peptide alone is not able to recapitulate the interactions observed in the p38α-HePTP complex. Instead, multiple NMR titration experiments of p38α with HePTP constructs of varying lengths and domain architectures, coupled with ITC, reveal that both the HePTP KIM31 and HePTP KIS sequences are necessary and sufficient to mediate all binding interactions with p38α. To our knowledge, this is the first time that residues outside a KIM of a MAPK effector protein have been determined at the molecular level.
Using SAXS, we have also shown that in solution the interactions mediated by the HePTP KIMKIS lead to the formation of a p38α-HePTP complex in which p38α and HePTP interact in an elongated, end-toend manner. This was unexpected because phosphorylated p38α is dephosphorylated by HePTP, which requires the formation of a more globular complex. However, it is clear from our SAXS studies that under resting-state conditions the p38α-HePTP complex is not globular but instead is highly elongated. This result differs considerably from that of a recently published crosslinking study 42 in which a resting-state PTP-SL-ERK2 complex was crosslinked and the structure of the complex was modeled using the crosslinking distances as constraints. Jointly, these results demonstrate that the overall orientation of MAPK-KIM-PTP resting-state complexes may differ depending on the MAPK, the KIM-PTP or both.
To generate a structural model for the p38α-HePTP complex in solution, we developed a new SAXS refinement procedure, EROS-NMR, which incorporates NMR chemical shift data into a recently developed SAXS refinement procedure. Incorporation of the NMR chemical shift data ensures that the models are consistent with not only the SAXS data, which define overall shape, but also the NMR chemical shift data, which define molecular interactions that direct the organization of the complex. As expected on the basis of multiple failed attempts to crystallize the resting-state complex, the SAXS refinements show that the complex is dynamic, as four models provide a better fit to the SAXS data than a single model. The models in the four-model ensemble have similar overall conformations, which differ primarily in the relative orientation of the HePTP CAT below the p38α C-terminal domain. The HePTP KIS conformation is variable, but adopts highly similar conformations as it projects downward from the p38α KIM binding pocket. The largest differences are observed in the C-terminal portion of the HePTP KIS , which adopts an extended conformation and interacts differentially with p38α in the four ensemble models of the p38α-HePTP complex. This shows that the N-terminal HePTP KIS residues interact directly with p38α, whereas the C-terminal HePTP KIS residues transiently bind p38α, allowing additional conformations to be sampled about the central dominant conformation (the single-best-fit conformation). This model is also consistent with a slight decrease in binding affinity between HePTP KIMKIS and HePTP with p38α, as measured by ITC, showing that this flexibility slightly lowers the overall strength of binding.
Taken together, these results provide fundamental new insights into the molecular basis of MAPK regulation and specificity. As additional similar studies are completed, the subset of residues outside the KIM binding pocket that are specific for different MAPK-MAPK regulatory protein complexes will be determined and, in turn, will allow for the development of new drug therapies that target these specific complexes. 
MeTHoDS
Sample preparation. The HePTP KIM31 peptide (VRLQERRGSNVALMLDV) was synthesized and HPLC purified (> 98% purity; Biosynthesis); the HePTP KIM30 peptide (RLQERRGSNVALMLD) was synthesized and HPLC purified (>98% purity; gift from J. Offer, University of Cambridge). Expression and purification of HePTP and HePTP CAT were carried out as previously described 14, 38 except that the final size-exclusion chromatography (SEC) step was carried out using p38α protein buffer (50 mM HEPES, pH 6.8, 150 mM NaCl, 5 mM dithiothreitol). p38α and the HePTP KIMKIS C42S peptide were subcloned into a derivative of the pET28 vector that includes an N-terminal His 6 tag and a TEV protease-recognition sequence 43 . Unlabeled proteins were expressed in BL21-(DE3) RIL Escherichia coli cells (Stratagene) in LB medium. N-TROSY spectra were recorded. All quantitative spin-label experiments were processed with NMRPipe 44 , and peak integrals were determined using CARA (http://www.nmr.ch/ doku.php). p38α-HePTP NMR interaction studies. Both HePTP KIM31 and HePTP KIM30 peptides were solubilized in protein buffer. Experiments were performed at ratios of 1:1, 1:3, 1:5 and 1:8 excess peptide, which were added to [
